Aldeyra Therapeutics, a biotech company, focuses on developing therapies for immune-mediated and metabolic diseases. Their lead product, reproxalap, is in Phase III trials for dry eye disease and allergic conjunctivitis. They also have other candidates in development for various conditions.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay